连云港地区幽门螺杆菌感染与非酒精性脂肪性肝病的关系

Abstract
Figure/Table
References (21)
Related Citation (15)

Download: PDF (647 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the relationship between Helicobacter pylori (Hp) infection and nonalcoholic fatty liver disease (NAFLD) in Lianyungang. Methods Clinical data of 8 125 people who had outpatient physical examinations in Lianyungang from January to December 2019 were retrospectively analyzed, 3 238 people with nonalcoholic fatty liver disease were divided into the NAFLD group, and 4887 normal people who underwent physical examinations during the same period were divided into the control group. The Hp infection situation of two groups of people was recorded, the Hp infection rate of two groups was calculated, and the relationship between NAFLD severity and Hp infection was analyzed. Results The total prevalence of NAFLD was 39.9%. The infection rate of Hp in the NAFLD group was higher than that in the control group, and the difference was statistically significant (P＜0.05). There was no significant difference between the severity of NAFLD and Hp infection in the NAFLD group (P＞0.05). Conclusion Hp infection rate of people with NAFLD in Lianyungang is higher than that of normal people, but there is no significant relationship between the severity of NAFLD and Hp infection.

Key words： Nonalcoholic fatty liver disease; Helicobacter pylori Infection Lianyungang

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIN Huanhuan
	ZHANG Hui
	SONG Chengwen
	ZHAO Changdong
	LUO Hongbo
	CHEN Xian

Cite this article:

LIN Huanhuan,ZHANG Hui,SONG Chengwen, et al. The relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease in Lianyungang[J]. 中国当代医药, 2022, 29(27): 49-51转55.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I27/49

[1]	Dyson JK，McPherson S，Anstee QM.Republished：Non-alcoholic fatty liver disease：non-invasive investigation and risk stratification[J].Postgrad Med J，2014，90（1063）：254-266.
[2]	丁雪娇，赵双清，李雅丽.非酒精性脂肪性肝病的流行病学及防治[J].中国临床保健杂志，2021，24（6）：742-746.
[3]	Li Z，Xue J，Chen P，et al.Prevalence of nonalcoholic fatty liver disease in mainland of China：a meta-analysis of published studies[J].J Gastroenterol Hepatol，2014，29（1）：42-51.
[4]	Wu J，Xu H，He X，et al.Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013[J].Sci Rep，2017，7：41518.
[5]	Dooley CP，Cohen H.The clinical significance of Campylobacter pylori[J].Ann Intern Med，1988，108（1）：70-79.
[6]	Atherton JC.The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases[J].Annu Rev Pathol，2006，1：63-96.
[7]	Sumida Y，Kanemasa K，Imai S，et al.Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease[J].J Gastroenterol，2015，50（9）：996-1004.
[8]	Kountouras J，Polyzos SA，Zavos C，et al.Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors[J].Hepatology，2014，60（4）：1450-1451.
[9]	袁晨，芦琳琳，辛永宁，等.幽门螺杆菌感染引发非酒精性脂肪性肝病机制的研究进展[J].中国肝脏病杂志（电子版），2016，8（3）：26-29.
[10]	陈长喜，郭传勇，毛玉山，等.中老年人群非酒精性脂肪性肝病和幽门螺杆菌感染的关系[J].中华消化杂志，2016，36（12）：839-842.
[11]	朱娜，黄童，虞荣斌，等.非酒精性脂肪性肝病与幽门螺杆菌感染的相关性研究[J].现代实用医学，2019，31（4）：462-465.
[12]	中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南（2018 更新版）[J].中华肝脏病杂志，2018，26（3）：195-203.
[13]	Kelley DE，McKolanis TM，Hegazi RA，et al.Fatty liver in type 2 diabetes mellitus: relation to regional adiposity，fatty acids，and insulin resistance[J].Am J Physiol Endocrinol Metab，2003，285（4）：906-916.
[14]	Yki-Jarvinen H.Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome[J].Lancet Diabetes Endocrinol，2014，2（11）：901-910.
[15]	中国中西医结合学会消化系统疾病专业委员会.非酒精性脂肪性肝病中医结合诊疗公示意见（2017年）[J].中国中西医结合消化杂志，2017，25（11）：805-811.
[16]	胡晓.益生菌辅助治疗非酒精性脂肪性肝病的效果[J].中国当代医药，2021，28（25）：167-170.
[17]	国家消化系疾病临床医学研究中心（上海），国家消化道早癌防治中心联盟（GECA），中华医学会消化病学分会幽门螺杆菌学组，等.中国幽门螺杆菌根除与胃癌防控的专家共识意见[J].中华消化杂志，2019，39（5）：310-316.
[18]	李瑞芳，卜淑蕊.肠道菌群与非酒精性脂肪性肝病研究进展[J].肝脏，2020，25（3）：328-330.
[19]	Dogan Z，Filik L，Ergül B，et al.Association between Helicobacter pylori and liver-to-spleen ratio：a randomizedcontrolled single-blind study[J].Eur J Gastroenterol Hepatol，2013，25（1）：107-110.
[20]	Chen C，Zhang C，Wang X，et al.Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage，glycometabolism，lipid metabolism，inflammatory reaction and metabolic syndrome[J].Eur J Gastroenterol Hepatol，2020，32（7）：857-866.
[21]	唐君瑞，李明珂，曹光琼，等.非酒精性脂肪性肝病与幽门螺杆菌感染的相关性[J].疑难病杂志，2020，19（3）：242-247.